CareRx Corporation (CHHHF)
USD 1.28
(0.0%)
USD 1.28
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 150.36 Million CAD | -24.85% |
| 2022 | 200.07 Million CAD | -0.22% |
| 2021 | 200.52 Million CAD | 38.48% |
| 2020 | 144.8 Million CAD | 35.28% |
| 2019 | 107.04 Million CAD | -17.81% |
| 2018 | 130.24 Million CAD | 4.72% |
| 2017 | 124.37 Million CAD | -18.25% |
| 2016 | 152.14 Million CAD | -58.05% |
| 2015 | 362.63 Million CAD | 4.43% |
| 2014 | 347.25 Million CAD | -7.74% |
| 2013 | 376.38 Million CAD | -3.9% |
| 2012 | 391.64 Million CAD | 4.42% |
| 2011 | 375.07 Million CAD | 1037.69% |
| 2010 | 32.96 Million CAD | 108.37% |
| 2009 | 15.82 Million CAD | 731.09% |
| 2008 | 1.9 Million CAD | -27.41% |
| 2007 | 2.62 Million CAD | 34.56% |
| 2006 | 1.94 Million CAD | -7.04% |
| 2005 | 2.09 Million CAD | 41.19% |
| 2004 | 1.48 Million CAD | 10.43% |
| 2003 | 1.34 Million CAD | 4149.57% |
| 2002 | 31.64 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 146.53 Million CAD | -2.55% |
| 2024 Q2 | 138.31 Million CAD | -5.61% |
| 2023 Q1 | 193.95 Million CAD | -3.06% |
| 2023 Q2 | 188.88 Million CAD | -2.61% |
| 2023 Q4 | 150.36 Million CAD | -19.16% |
| 2023 FY | 150.36 Million CAD | -24.85% |
| 2023 Q3 | 186.01 Million CAD | -1.52% |
| 2022 Q2 | 198.6 Million CAD | -2.28% |
| 2022 Q4 | 200.07 Million CAD | 1.71% |
| 2022 FY | 200.07 Million CAD | -0.22% |
| 2022 Q1 | 203.24 Million CAD | 1.36% |
| 2022 Q3 | 196.72 Million CAD | -0.95% |
| 2021 FY | 200.52 Million CAD | 38.48% |
| 2021 Q2 | 144.65 Million CAD | 0.5% |
| 2021 Q3 | 205 Million CAD | 41.72% |
| 2021 Q4 | 200.52 Million CAD | -2.18% |
| 2021 Q1 | 143.93 Million CAD | -0.6% |
| 2020 Q2 | 153.35 Million CAD | 45.83% |
| 2020 Q1 | 105.16 Million CAD | -1.76% |
| 2020 Q4 | 144.8 Million CAD | 3.41% |
| 2020 FY | 144.8 Million CAD | 35.28% |
| 2020 Q3 | 140.03 Million CAD | -8.69% |
| 2019 Q4 | 107.04 Million CAD | -28.71% |
| 2019 Q2 | 148.73 Million CAD | -3.26% |
| 2019 FY | 107.04 Million CAD | -17.81% |
| 2019 Q3 | 150.14 Million CAD | 0.95% |
| 2019 Q1 | 153.75 Million CAD | 18.05% |
| 2018 Q2 | 122.89 Million CAD | -1.84% |
| 2018 FY | 130.24 Million CAD | 4.72% |
| 2018 Q4 | 130.24 Million CAD | 1.46% |
| 2018 Q3 | 128.37 Million CAD | 4.46% |
| 2018 Q1 | 125.2 Million CAD | 0.66% |
| 2017 Q3 | 125.42 Million CAD | -0.89% |
| 2017 Q4 | 124.37 Million CAD | -0.83% |
| 2017 FY | 124.37 Million CAD | -18.25% |
| 2017 Q1 | 137.19 Million CAD | -9.83% |
| 2017 Q2 | 126.55 Million CAD | -7.76% |
| 2016 Q3 | 139.99 Million CAD | 6.83% |
| 2016 Q1 | 130.3 Million CAD | -64.07% |
| 2016 Q4 | 152.14 Million CAD | 8.68% |
| 2016 FY | 152.14 Million CAD | -58.05% |
| 2016 Q2 | 131.04 Million CAD | 0.57% |
| 2015 FY | 362.63 Million CAD | 4.43% |
| 2015 Q1 | 373.53 Million CAD | 7.57% |
| 2015 Q2 | 364.69 Million CAD | -2.37% |
| 2015 Q3 | 359.37 Million CAD | -1.46% |
| 2015 Q4 | 362.63 Million CAD | 0.91% |
| 2014 Q2 | 381.4 Million CAD | 0.6% |
| 2014 FY | 347.25 Million CAD | -7.74% |
| 2014 Q4 | 347.25 Million CAD | -0.89% |
| 2014 Q1 | 379.13 Million CAD | 0.73% |
| 2014 Q3 | 350.36 Million CAD | -8.14% |
| 2013 Q1 | 381.95 Million CAD | -2.48% |
| 2013 Q2 | 387.27 Million CAD | 1.39% |
| 2013 Q3 | 376.02 Million CAD | -2.91% |
| 2013 Q4 | 376.38 Million CAD | 0.1% |
| 2013 FY | 376.38 Million CAD | -3.9% |
| 2012 Q2 | 374.49 Million CAD | -12.03% |
| 2012 FY | 391.64 Million CAD | 4.42% |
| 2012 Q4 | 391.64 Million CAD | 5.53% |
| 2012 Q3 | 371.13 Million CAD | -0.9% |
| 2012 Q1 | 425.67 Million CAD | 13.49% |
| 2011 Q2 | 395.26 Million CAD | 722.43% |
| 2011 Q4 | 375.07 Million CAD | 3.13% |
| 2011 Q3 | 363.68 Million CAD | -7.99% |
| 2011 FY | 375.07 Million CAD | 1037.69% |
| 2011 Q1 | 48.06 Million CAD | 45.78% |
| 2010 Q4 | 32.96 Million CAD | 94.33% |
| 2010 Q1 | 16.26 Million CAD | 2.82% |
| 2010 Q2 | 17.43 Million CAD | 7.15% |
| 2010 Q3 | 16.96 Million CAD | -2.67% |
| 2010 FY | 32.96 Million CAD | 108.37% |
| 2009 Q2 | 16.1 Million CAD | 820.22% |
| 2009 Q3 | 15.96 Million CAD | -0.85% |
| 2009 FY | 15.82 Million CAD | 731.09% |
| 2009 Q4 | 15.82 Million CAD | -0.9% |
| 2009 Q1 | 1.74 Million CAD | -8.09% |
| 2008 Q3 | 1.68 Million CAD | -4.2% |
| 2008 Q4 | 1.9 Million CAD | 13.25% |
| 2008 Q1 | 2.58 Million CAD | -1.54% |
| 2008 Q2 | 1.75 Million CAD | -32.04% |
| 2008 FY | 1.9 Million CAD | -27.41% |
| 2007 Q3 | 1.44 Million CAD | -22.63% |
| 2007 FY | 2.62 Million CAD | 34.56% |
| 2007 Q4 | 2.62 Million CAD | 81.77% |
| 2007 Q2 | 1.86 Million CAD | -5.36% |
| 2007 Q1 | 1.97 Million CAD | 1.1% |
| 2006 Q4 | 1.94 Million CAD | 3.51% |
| 2006 Q1 | 1.87 Million CAD | -10.41% |
| 2006 Q2 | 2.03 Million CAD | 8.23% |
| 2006 Q3 | 1.88 Million CAD | -7.39% |
| 2006 FY | 1.94 Million CAD | -7.04% |
| 2005 Q4 | 2.09 Million CAD | 11.07% |
| 2005 Q2 | 1.5 Million CAD | 7.65% |
| 2005 Q1 | 1.39 Million CAD | -5.72% |
| 2005 Q3 | 1.88 Million CAD | 25.25% |
| 2005 FY | 2.09 Million CAD | 41.19% |
| 2004 Q2 | 1.11 Million CAD | -6.11% |
| 2004 Q3 | 1.07 Million CAD | -3.15% |
| 2004 Q1 | 1.18 Million CAD | -12.07% |
| 2004 Q4 | 1.48 Million CAD | 38.1% |
| 2004 FY | 1.48 Million CAD | 10.43% |
| 2003 Q1 | 34.17 Thousand CAD | 7.99% |
| 2003 FY | 1.34 Million CAD | 4149.57% |
| 2003 Q3 | 1.63 Million CAD | -12.42% |
| 2003 Q2 | 1.86 Million CAD | 5359.69% |
| 2003 Q4 | 1.34 Million CAD | -17.7% |
| 2002 Q3 | 2734.00 CAD | 0.0% |
| 2002 Q4 | 31.64 Thousand CAD | 1057.43% |
| 2002 FY | 31.64 Thousand CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | -508.536% |
| Arem Pacific Corporation | 304.9 Thousand USD | -49216.34% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -81547.092% |
| BioCorRx Inc. | 10.34 Million USD | -1354.028% |
| Bionik Laboratories Corp. | 5 Million USD | -2905.708% |
| Banyan Corp. | 4.51 Million USD | -3227.857% |
| Clearday, Inc. | 65.13 Million USD | -130.865% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -8243.983% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -9997572.903% |
| Empower Clinics Inc. | 9.18 Million USD | -1536.961% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | -375.044% |
| Selectis Health, Inc. | 43.63 Million USD | -244.6% |
| Ethema Health Corporation | 17.71 Million USD | -748.598% |
| HealthLynked Corp. | 3.47 Million USD | -4226.597% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -938.823% |
| JRSIS Health Care Corporation | 2.3 Million USD | -6423.013% |
| Comjoyful International Company | 6.32 Million USD | -2276.932% |
| Medical Facilities Corporation | 235.37 Million USD | 36.115% |
| MedSmart Group Inc. | 927.53 Thousand USD | -16111.534% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -15950.275% |
| Nova Leap Health Corp. | 2.69 Million USD | -5471.302% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -5117.212% |
| PAO Group, Inc. | 1.04 Million USD | -14267.711% |
| Primemd Inc. | 7.98 Million USD | -1782.248% |
| Raffles Medical Group Ltd | 367.04 Million USD | 59.033% |
| Ryman Healthcare Limited | 5.17 Billion USD | 97.097% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -186633.313% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -3739.989% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -3439.944% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -22143.639% |
| Veltex Corporation | 2.87 Million USD | -5126.088% |
| World Financial Holding Group | 132.5 Thousand USD | -113380.246% |
| Xcelerate Inc. | 2.07 Million USD | -7144.612% |